These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 29679795

  • 1. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
    Liang C, Wang H, Zhang M, Cheng W, Li Z, Nie J, Liu G, Lian D, Xie Z, Huang L, Zeng X.
    J Colloid Interface Sci; 2018 Sep 01; 525():1-10. PubMed ID: 29679795
    [Abstract] [Full Text] [Related]

  • 2. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H.
    Mater Sci Eng C Mater Biol Appl; 2018 Mar 01; 84():108-117. PubMed ID: 29519418
    [Abstract] [Full Text] [Related]

  • 3. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y, Guo Y, Zhuang X, Li D, Cheng B, Tan S, Zhang Z.
    Mol Pharm; 2014 Sep 02; 11(9):3196-209. PubMed ID: 25102234
    [Abstract] [Full Text] [Related]

  • 4. Differential Effects of Polymer-Surface Decoration on Drug Delivery, Cellular Retention, and Action Mechanisms of Functionalized Mesoporous Silica Nanoparticles.
    You Y, Hu H, He L, Chen T.
    Chem Asian J; 2015 Dec 02; 10(12):2744-54. PubMed ID: 26248202
    [Abstract] [Full Text] [Related]

  • 5. TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance.
    Cheng W, Liang C, Xu L, Liu G, Gao N, Tao W, Luo L, Zuo Y, Wang X, Zhang X, Zeng X, Mei L.
    Small; 2017 Aug 02; 13(29):. PubMed ID: 28594473
    [Abstract] [Full Text] [Related]

  • 6. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
    Li N, Fu T, Fei W, Han T, Gu X, Hou Y, Liu Y, Yang J.
    J Pharm Pharmacol; 2019 Aug 02; 71(8):1243-1254. PubMed ID: 31215039
    [Abstract] [Full Text] [Related]

  • 7. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T, Chen D, Liu K, Qi Y, Tian Y, Sun P, Liu Y, Li Z.
    ACS Appl Mater Interfaces; 2015 Aug 19; 7(32):18064-75. PubMed ID: 26214761
    [Abstract] [Full Text] [Related]

  • 8. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.
    Han N, Zhao Q, Wan L, Wang Y, Gao Y, Wang P, Wang Z, Zhang J, Jiang T, Wang S.
    ACS Appl Mater Interfaces; 2015 Feb 11; 7(5):3342-51. PubMed ID: 25584634
    [Abstract] [Full Text] [Related]

  • 9. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.
    Nanotechnology; 2011 Nov 11; 22(45):455102. PubMed ID: 22019849
    [Abstract] [Full Text] [Related]

  • 10. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S, Liu Y, Wang T, Zhang J, Jiang D, Yu X, Zhang N.
    Acta Biomater; 2017 Nov 11; 63():150-162. PubMed ID: 28873341
    [Abstract] [Full Text] [Related]

  • 11. Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells.
    Li PY, Lai PS, Hung WC, Syu WJ.
    Biomacromolecules; 2010 Oct 11; 11(10):2576-82. PubMed ID: 20722436
    [Abstract] [Full Text] [Related]

  • 12. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.
    Suksiriworapong J, Phoca K, Ngamsom S, Sripha K, Moongkarndi P, Junyaprasert VB.
    Eur J Pharm Biopharm; 2016 Apr 11; 101():15-24. PubMed ID: 26802701
    [Abstract] [Full Text] [Related]

  • 13. Star-shaped polymer of β‑cyclodextrin-g-vitamin E TPGS for doxorubicin delivery and multidrug resistance inhibition.
    Yang C, Qin Y, Tu K, Xu C, Li Z, Zhang Z.
    Colloids Surf B Biointerfaces; 2018 Sep 01; 169():10-19. PubMed ID: 29747026
    [Abstract] [Full Text] [Related]

  • 14. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q, Zhao H, Li D, Liu L, Du S.
    Colloids Surf B Biointerfaces; 2017 Jan 01; 149():138-145. PubMed ID: 27750088
    [Abstract] [Full Text] [Related]

  • 15. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects.
    Mi Y, Zhao J, Feng SS.
    Int J Pharm; 2012 Nov 15; 438(1-2):98-106. PubMed ID: 22954445
    [Abstract] [Full Text] [Related]

  • 16. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
    Xu W, Ge P, Niu B, Zhang X, Liu J, Xie J.
    J Colloid Interface Sci; 2018 Oct 01; 527():141-150. PubMed ID: 29787950
    [Abstract] [Full Text] [Related]

  • 17. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D, Gao Y, Wang L, Liu G, Chen Y, Wang T, Tao W, Mei L, Huang L, Zeng X.
    J Colloid Interface Sci; 2016 Feb 01; 463():279-87. PubMed ID: 26550786
    [Abstract] [Full Text] [Related]

  • 18. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
    Zhang X, Li F, Guo S, Chen X, Wang X, Li J, Gan Y.
    Biomaterials; 2014 Apr 01; 35(11):3650-65. PubMed ID: 24462359
    [Abstract] [Full Text] [Related]

  • 19. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.
    Mi Y, Zhao J, Feng SS.
    J Control Release; 2013 Aug 10; 169(3):185-92. PubMed ID: 23403395
    [Abstract] [Full Text] [Related]

  • 20. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y, Yin M, Hu X, Zhuang X, Sun Y, Guo Y, Tan S, Zhang Z.
    J Control Release; 2016 Aug 10; 235():182-194. PubMed ID: 27264552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.